Its first client, Haystack Bio, will use Genecloud to analyze and store single-cell genomics data for a proprietary platform it is developing for the immunotherapy market.
Takara said it will pay an aggregate cash purchase price that will be based on a multiple of WaferGen's 2016 revenues, capped at $50 million.
The genomics company said the new agreements cover South Korea, Australia, New Zealand, Southeast Asia, and China.
The company said it placed two ICell8 Single-Cell Systems during the quarter, doubling the number of systems placed since the product's launch last October.
The firm said that product revenues in Q4 2015 were up about 50 percent year over year, while license and royalty revenues remained flat.
After scrapping initial plans to develop a diagnostic instrument, the company has been working for several years to advance its single-cell droplet platform for targeted drug development.
Fluidigm reported total revenues of $30.7 million, within its preannouncement range and ahead of analysts' consensus estimate.
The company attributed the growth in quarterly revenue to sales of its existing products and early interest in its new single-cell genomics system.
The South San Francisco-based genomics tools company reported $28.6 million in total revenues compared to $29.6 million in the year-ago period.
The firm expects to raise net proceeds of $13.6 million, which it will use to advance development and commercialization of its single-cell genomics products.
The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.
Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.
Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.
In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.